Clinical Trial Update: Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing sirolimus alone versus sirolimus with prednisolone for Kaposiform Hemangioendothelioma, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma
• Kasabach Merritt Phenomenon

Drugs mentioned

• Prednisolone (Prednisolone)
• Sirolimus (Sirolimus)

Snippet

Sponsor: West China Hospital | Conditions: Kaposiform Hemangioendothelioma, Kasabach Merritt Phenomenon | Phase 2 | Status: COMPLETED